Explicyte
Biotechnology ResearchView the employees at
Explicyte-
Jean-Philippe Guégan Study Director at Explicyte
-
Bordeaux, Nouvelle-Aquitaine, France
-
Top 5%
Loic Cerf Chief Operating Officer at ImmuSmol / Explicyte-
Bordeaux, Nouvelle-Aquitaine, France
-
Rising Star
Corentin PIGNON Technicien de laboratoire-
Villenave-d’Ornon, Nouvelle-Aquitaine, France
-
Rising Star
Imane Nafia Chief Scientific Officer - Explicyte-
Greater Bordeaux Metropolitan Area
-
Rising Star
Lucie Lefèvre Ingénieur recherche chez Explicyte-
Bordeaux, Nouvelle-Aquitaine, France
-
Rising Star
Overview
Explicyte is a family brand of specialty preclinical services launched by ImmuSmol, a bordeaux-based company. The first brand, Explicyte Immune-Oncology offers preclinical contract research services in immuno-oncology. Explicyte Immuno-Oncology currently offers to test innovative cancer immunotherapies in vivo, using syngeneic mouse tumor models treated with immune checkpoint inhibitors (eg. anti-CTLA-4 and anti-PD1/PD-L1 antibodies). In addition, Explicyte is setting up an in vitro platform for the identification and optimization of novel immunomodulators. Equipped with high-content analysis technologies, the platform focuses on live phenotypic screening in co-cultures of immune and cancer cells, as well as molecular cell-based assays for the assessment of immune checkpoint inhibitors.
-